Research output

Can medical products be developed on a non-profit basis? Exploring product development partnerships for neglected diseases

Research output: Contribution to journalArticleAcademicpeer-review

Standard

Can medical products be developed on a non-profit basis? Exploring product development partnerships for neglected diseases. / Munoz, V.; Visentin, F.; Foray, D.; Gaule, P.

In: Science and Public Policy, Vol. 42, No. 3, 06.2015, p. 315-338.

Research output: Contribution to journalArticleAcademicpeer-review

Harvard

APA

Vancouver

Author

Bibtex

@article{8d8e023725ca493487a14cf840596aaa,
title = "Can medical products be developed on a non-profit basis? Exploring product development partnerships for neglected diseases",
abstract = "Reliance on market forces can lead to underinvestment in social welfare enhancing innovation. The lack of new medical products in the area of neglected diseases is a case in point. R&D for neglected diseases has increased with new funding and collaborations taking place mainly through product development partnerships (PDPs). PDPs are self-governing, private non-profit R&D organizations. In contrast to push and pull instruments designed to address private-sector R&D underinvestment, PDPs have emerged voluntarily to address this public health challenge. In this study we examine how non-profit R&D collaboration for neglected diseases takes place through PDPs. We find that PDPs act as 'system integrators' that leverage the resources and capabilities of a network of public, philanthropic and private-sector partners.",
keywords = "R&D collaboration, non-profit, innovation, neglected diseases, RESEARCH-AND-DEVELOPMENT, DRUG DEVELOPMENT, PHARMACEUTICAL INNOVATION, DISCOVERY, MARKET, ECONOMICS, ADVANCE, POLICY, SCALE, SCOPE",
author = "V. Munoz and F. Visentin and D. Foray and P. Gaule",
year = "2015",
month = "6",
doi = "10.1093/scipol/scu049",
language = "English",
volume = "42",
pages = "315--338",
journal = "Science and Public Policy",
issn = "0302-3427",
publisher = "Oxford University Press",
number = "3",

}

RIS

TY - JOUR

T1 - Can medical products be developed on a non-profit basis? Exploring product development partnerships for neglected diseases

AU - Munoz, V.

AU - Visentin, F.

AU - Foray, D.

AU - Gaule, P.

PY - 2015/6

Y1 - 2015/6

N2 - Reliance on market forces can lead to underinvestment in social welfare enhancing innovation. The lack of new medical products in the area of neglected diseases is a case in point. R&D for neglected diseases has increased with new funding and collaborations taking place mainly through product development partnerships (PDPs). PDPs are self-governing, private non-profit R&D organizations. In contrast to push and pull instruments designed to address private-sector R&D underinvestment, PDPs have emerged voluntarily to address this public health challenge. In this study we examine how non-profit R&D collaboration for neglected diseases takes place through PDPs. We find that PDPs act as 'system integrators' that leverage the resources and capabilities of a network of public, philanthropic and private-sector partners.

AB - Reliance on market forces can lead to underinvestment in social welfare enhancing innovation. The lack of new medical products in the area of neglected diseases is a case in point. R&D for neglected diseases has increased with new funding and collaborations taking place mainly through product development partnerships (PDPs). PDPs are self-governing, private non-profit R&D organizations. In contrast to push and pull instruments designed to address private-sector R&D underinvestment, PDPs have emerged voluntarily to address this public health challenge. In this study we examine how non-profit R&D collaboration for neglected diseases takes place through PDPs. We find that PDPs act as 'system integrators' that leverage the resources and capabilities of a network of public, philanthropic and private-sector partners.

KW - R&D collaboration

KW - non-profit

KW - innovation

KW - neglected diseases

KW - RESEARCH-AND-DEVELOPMENT

KW - DRUG DEVELOPMENT

KW - PHARMACEUTICAL INNOVATION

KW - DISCOVERY

KW - MARKET

KW - ECONOMICS

KW - ADVANCE

KW - POLICY

KW - SCALE

KW - SCOPE

U2 - 10.1093/scipol/scu049

DO - 10.1093/scipol/scu049

M3 - Article

VL - 42

SP - 315

EP - 338

JO - Science and Public Policy

T2 - Science and Public Policy

JF - Science and Public Policy

SN - 0302-3427

IS - 3

ER -